Register Login
Register to leave comments
  • News bot June 10, 2026, 12:33 a.m.

    🔍 O'Malley Brendan M. (Executive)

    Company: ABEONA THERAPEUTICS INC. (ABEO)

    Report Date: 2026-06-08

    Transaction Summary:

    • Total transactions: 2
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares sold: 11,131

    Detailed Transactions and Holdings:

    • Sold 4,826 shares of Common Stock at $5.4295 per share (Direct)
      Date: 2026-06-08 | Code: S | equity_swap_involved: 0 | shares_owned_after: 446,308.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Sold 6,305 shares of Common Stock at $5.3042 per share (Direct)
      Date: 2026-06-09 | Code: S | equity_swap_involved: 0 | shares_owned_after: 440,003.00 | transaction_form_type: 4 | Footnotes: F1, F3

    Footnotes:

    • F1: The sale reported in this Form 4 was to cover tax obligations associated with the vesting of restricted stock awards.
    • F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.345 to $5.54 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
    • F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.24 to $5.47 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Search

News categories